BMRN insider trading — Biomarin Pharmaceutical Inc
Over the last 90 days, insiders at Biomarin Pharmaceutical Inc (BMRN) made 0 open-market purchases worth $0 and 1 open-market sale worth $1.16M, making them net sellers by $1.16M. The largest sale was by Davis George Eric (EVP, Chief Legal Officer), who sold 17,557 shares for $1.16M on Sep 2, 2026.
Updated Oct 16, 2026.
Recent BMRN insider transactions
Every Form 4 filed by Biomarin Pharmaceutical Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Friberg Gregory R | EVP, Chief R&D Officer | F · Tax withholding | Direct | 4,086 | $60.00 | $245K | Form 4 |
| Sep 10, 2026 | Plenge Robert M | Director | A · Grant/award | Direct | 6,140 | — | — | Form 4 |
| Sep 2, 2026 | Davis George Eric | EVP, Chief Legal Officer | S · Sale | Direct | 17,557 | $66.28 | $1.16M | Form 4 |
BMRN insider trading FAQ
Are insiders buying BMRN stock?
Not on the open market. In the last 90 days, Biomarin Pharmaceutical Inc insiders made no open-market purchases, and 1 open-market sale totaling $1.16M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading BMRN?
Recent sellers: Davis George Eric.
Where does BMRN insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.